Bimonthly Survey

Please indicate if you have used resources and/or trainings from any of the following in the past 12 months.
Select all that apply
Are you familiar with the AETC Program HIV Care Tools App?

Description

Graphic image

Join the Southeast AETC for this five-session series that explores how to implement Long-Acting Injectables (LAI) in real-world settings by integrating clinical and nonclinical workflows, centering on patient experience and shared decision-making, optimizing prescribing practices, addressing coverage and access barriers, and using clinical monitoring and process indicators to drive quality improvement.

Objectives

  • Review the clinical trials that led to the approval of long-acting cabotegravir and rilpivirine, and understand their limitations
  • Interpret real-world data, including outcomes in patients not included in the original FDA label
  • Identify clinical and structural considerations when initiating and maintaining long-acting injectable ART
  • Discuss emerging long-acting therapies and how they may shape future treatment strategies

Speaker

Jason Zucker, MD
Assistant Professor of Medicine, Columbia University Irving Medical Center
PI and Co-Medical Director, New York City STD Prevention Training Center

For inquiry, contact Alexandria Anderson via [email protected]

More events in this series